Development of Triazoles and Triazolium Salts Based on AZT and Their Anti-Viral Activity against HIV-1

We report herein a set of 3′-azido-3′-deoxythymidine (AZT) derivatives based on triazoles and triazolium salts for HIV-1 infection. The compounds were synthesized via click chemistry with Cu(I) and Ru(II) catalysts. Triazolium salts were synthesized by reaction with methyl iodide or methyl triflate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniel Machado de Alencar, Juliana Gonçalves, Andreia Vieira, Sofia A. Cerqueira, Cruz Sebastião, Maria Inês P. S. Leitão, Giulia Francescato, Paola Antenori, Helena Soares, Ana Petronilho
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
AZT
Acceso en línea:https://doaj.org/article/0091e9d5698e4f5bb5caca695adc3782
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0091e9d5698e4f5bb5caca695adc3782
record_format dspace
spelling oai:doaj.org-article:0091e9d5698e4f5bb5caca695adc37822021-11-11T18:39:40ZDevelopment of Triazoles and Triazolium Salts Based on AZT and Their Anti-Viral Activity against HIV-110.3390/molecules262167201420-3049https://doaj.org/article/0091e9d5698e4f5bb5caca695adc37822021-11-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6720https://doaj.org/toc/1420-3049We report herein a set of 3′-azido-3′-deoxythymidine (AZT) derivatives based on triazoles and triazolium salts for HIV-1 infection. The compounds were synthesized via click chemistry with Cu(I) and Ru(II) catalysts. Triazolium salts were synthesized by reaction with methyl iodide or methyl triflate in good yields. The antiviral activity of the compounds was tested using two methodologies: In method one the activity was measured on infected cells; in method two a pre-exposure prophylaxis experimental model was employed. For method one the activity of the compounds was moderate, and in general the triazolium salts showed a decreased activity in relation to their triazole precursors. With method two the antiviral activity was higher. All compounds were able to decrease the infection, with two compounds able to clear almost all the infection, while a lower antiviral activity was noted for the triazolium salts. These results suggest that these drugs could play an important role in the development of pre-exposure prophylaxis therapies.Daniel Machado de AlencarJuliana GonçalvesAndreia VieiraSofia A. CerqueiraCruz SebastiãoMaria Inês P. S. LeitãoGiulia FrancescatoPaola AntenoriHelena SoaresAna PetronilhoMDPI AGarticleclick chemistrytriazolestriazolium saltsanti-viralHIV-1AZTOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6720, p 6720 (2021)
institution DOAJ
collection DOAJ
language EN
topic click chemistry
triazoles
triazolium salts
anti-viral
HIV-1
AZT
Organic chemistry
QD241-441
spellingShingle click chemistry
triazoles
triazolium salts
anti-viral
HIV-1
AZT
Organic chemistry
QD241-441
Daniel Machado de Alencar
Juliana Gonçalves
Andreia Vieira
Sofia A. Cerqueira
Cruz Sebastião
Maria Inês P. S. Leitão
Giulia Francescato
Paola Antenori
Helena Soares
Ana Petronilho
Development of Triazoles and Triazolium Salts Based on AZT and Their Anti-Viral Activity against HIV-1
description We report herein a set of 3′-azido-3′-deoxythymidine (AZT) derivatives based on triazoles and triazolium salts for HIV-1 infection. The compounds were synthesized via click chemistry with Cu(I) and Ru(II) catalysts. Triazolium salts were synthesized by reaction with methyl iodide or methyl triflate in good yields. The antiviral activity of the compounds was tested using two methodologies: In method one the activity was measured on infected cells; in method two a pre-exposure prophylaxis experimental model was employed. For method one the activity of the compounds was moderate, and in general the triazolium salts showed a decreased activity in relation to their triazole precursors. With method two the antiviral activity was higher. All compounds were able to decrease the infection, with two compounds able to clear almost all the infection, while a lower antiviral activity was noted for the triazolium salts. These results suggest that these drugs could play an important role in the development of pre-exposure prophylaxis therapies.
format article
author Daniel Machado de Alencar
Juliana Gonçalves
Andreia Vieira
Sofia A. Cerqueira
Cruz Sebastião
Maria Inês P. S. Leitão
Giulia Francescato
Paola Antenori
Helena Soares
Ana Petronilho
author_facet Daniel Machado de Alencar
Juliana Gonçalves
Andreia Vieira
Sofia A. Cerqueira
Cruz Sebastião
Maria Inês P. S. Leitão
Giulia Francescato
Paola Antenori
Helena Soares
Ana Petronilho
author_sort Daniel Machado de Alencar
title Development of Triazoles and Triazolium Salts Based on AZT and Their Anti-Viral Activity against HIV-1
title_short Development of Triazoles and Triazolium Salts Based on AZT and Their Anti-Viral Activity against HIV-1
title_full Development of Triazoles and Triazolium Salts Based on AZT and Their Anti-Viral Activity against HIV-1
title_fullStr Development of Triazoles and Triazolium Salts Based on AZT and Their Anti-Viral Activity against HIV-1
title_full_unstemmed Development of Triazoles and Triazolium Salts Based on AZT and Their Anti-Viral Activity against HIV-1
title_sort development of triazoles and triazolium salts based on azt and their anti-viral activity against hiv-1
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/0091e9d5698e4f5bb5caca695adc3782
work_keys_str_mv AT danielmachadodealencar developmentoftriazolesandtriazoliumsaltsbasedonaztandtheirantiviralactivityagainsthiv1
AT julianagoncalves developmentoftriazolesandtriazoliumsaltsbasedonaztandtheirantiviralactivityagainsthiv1
AT andreiavieira developmentoftriazolesandtriazoliumsaltsbasedonaztandtheirantiviralactivityagainsthiv1
AT sofiaacerqueira developmentoftriazolesandtriazoliumsaltsbasedonaztandtheirantiviralactivityagainsthiv1
AT cruzsebastiao developmentoftriazolesandtriazoliumsaltsbasedonaztandtheirantiviralactivityagainsthiv1
AT mariainespsleitao developmentoftriazolesandtriazoliumsaltsbasedonaztandtheirantiviralactivityagainsthiv1
AT giuliafrancescato developmentoftriazolesandtriazoliumsaltsbasedonaztandtheirantiviralactivityagainsthiv1
AT paolaantenori developmentoftriazolesandtriazoliumsaltsbasedonaztandtheirantiviralactivityagainsthiv1
AT helenasoares developmentoftriazolesandtriazoliumsaltsbasedonaztandtheirantiviralactivityagainsthiv1
AT anapetronilho developmentoftriazolesandtriazoliumsaltsbasedonaztandtheirantiviralactivityagainsthiv1
_version_ 1718431742650482688